DE69124115D1 - Methode zur herstellung von systemen mit kontrollierter freisetzung nach einer reaktion nullter ordnung - Google Patents

Methode zur herstellung von systemen mit kontrollierter freisetzung nach einer reaktion nullter ordnung

Info

Publication number
DE69124115D1
DE69124115D1 DE69124115T DE69124115T DE69124115D1 DE 69124115 D1 DE69124115 D1 DE 69124115D1 DE 69124115 T DE69124115 T DE 69124115T DE 69124115 T DE69124115 T DE 69124115T DE 69124115 D1 DE69124115 D1 DE 69124115D1
Authority
DE
Germany
Prior art keywords
controlled release
zero order
release systems
order reaction
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69124115T
Other languages
English (en)
Other versions
DE69124115T2 (de
Inventor
Donald R Cowsar
Richard L Dunn
Thomas J Laughlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southern Research Institute
Original Assignee
Southern Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Southern Research Institute filed Critical Southern Research Institute
Application granted granted Critical
Publication of DE69124115D1 publication Critical patent/DE69124115D1/de
Publication of DE69124115T2 publication Critical patent/DE69124115T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69124115T 1988-12-02 1991-05-08 Methode zur herstellung von systemen mit kontrollierter freisetzung nach einer reaktion nullter ordnung Expired - Fee Related DE69124115T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/279,216 US5085866A (en) 1988-12-02 1988-12-02 Method of producing zero-order controlled-released devices
PCT/US1991/003178 WO1992019283A1 (en) 1988-12-02 1991-05-08 Method of producing zero-order controlled-release devices

Publications (2)

Publication Number Publication Date
DE69124115D1 true DE69124115D1 (de) 1997-02-20
DE69124115T2 DE69124115T2 (de) 1997-07-10

Family

ID=37400868

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69124115T Expired - Fee Related DE69124115T2 (de) 1988-12-02 1991-05-08 Methode zur herstellung von systemen mit kontrollierter freisetzung nach einer reaktion nullter ordnung

Country Status (7)

Country Link
US (1) US5085866A (de)
EP (1) EP0583244B1 (de)
JP (1) JPH06507379A (de)
AT (1) ATE147262T1 (de)
DE (1) DE69124115T2 (de)
ES (1) ES2098495T3 (de)
WO (1) WO1992019283A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5807407A (en) * 1992-05-04 1998-09-15 Biomet, Inc. Medical implant device and method for making same
US5466530A (en) * 1993-01-21 1995-11-14 England; Garry L. Biocompatible components fabricated from a substantially consolidated stock of material
US5607686A (en) * 1994-11-22 1997-03-04 United States Surgical Corporation Polymeric composition
ES2158611T3 (es) 1996-12-20 2001-09-01 Alza Corp Composicion en gel inyectable con efecto retard y procedimiento para la preparacion de dicha composicion.
CA2270975C (en) 1997-07-02 2003-04-01 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
EP1949890A3 (de) 1999-06-04 2011-05-18 ALZA Corporation Implantierbare Gelzusammensetzungen und Herstellungsverfahren dafür
EP1237544A1 (de) * 1999-12-16 2002-09-11 Trident Technologies, LLC System und verfahren zur gleichzeitigen verabreichung einer dosis mit verlängerter freisetzung und einer dosis zur rezeptorbeladung eines therapeutischen wirkstoffs
US20030211974A1 (en) * 2000-03-21 2003-11-13 Brodbeck Kevin J. Gel composition and methods
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
ES2329346T3 (es) * 2001-11-14 2009-11-25 Durect Corporation Composicion de deposito inyectable.
IL162001A0 (en) * 2001-11-14 2005-11-20 Alza Corp Catheter injectable depot compositions and uses thereof
WO2003041684A2 (en) * 2001-11-14 2003-05-22 Alza Corporation Injectable depot compositions and uses thereof
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
TWI353854B (en) 2002-06-25 2011-12-11 Alza Corp Short duration depot formulations
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
AU2002359397B2 (en) * 2002-07-31 2009-01-29 Durect Corporation Injectable depot compositions and uses thereof
NZ537953A (en) 2002-07-31 2007-02-23 Alza Corp Injectable multimodal polymer depot compositions and uses thereof
KR20050088288A (ko) * 2002-11-06 2005-09-05 알자 코포레이션 제어식 방출 데포 제형
US20070184084A1 (en) * 2003-05-30 2007-08-09 Guohua Chen Implantable elastomeric caprolactone depot compositions and uses thereof
WO2004108111A1 (en) * 2003-05-30 2004-12-16 Alza Corporation Implantable elastomeric depot compositions, uses thereof and method of manufacturing
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
US20080008759A1 (en) * 2006-05-30 2008-01-10 Den-Mat Corporation Method of improving wound healing
GB0613552D0 (en) * 2006-07-07 2006-08-16 Univ Heriot Watt Resorbable insert
BRPI0913809B1 (pt) 2008-10-02 2019-02-05 Mylan Inc método para produzir continuamente um laminado adesivo sensível á pressão multicamada
DE102009022893A1 (de) 2009-05-27 2010-12-02 Bayer Technology Services Gmbh Pulverformulierungen mit Adsorbens-Partikeln
EP3079668A1 (de) 2013-12-09 2016-10-19 Durect Corporation Pharmazeutisch aktive wirkstoffkomplexe, polymerkomplexe und zusammensetzungen und verfahren damit
US9717660B2 (en) * 2014-02-28 2017-08-01 Regents Of The University Of Minnesota Fluoride releasing dental composition and dental appliance
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CN107648663A (zh) * 2016-07-25 2018-02-02 薪创生命科技有限公司 新的骨材料替代合成配方、制备方法和使用方法
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5464630A (en) * 1977-10-31 1979-05-24 Nippon Kayaku Co Ltd Base for film coating
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
IT1213080B (it) * 1986-06-17 1989-12-07 Recordati Chem Pharm Sistemi terapeutico per la cessione controllata di farmaci.
EP0325086A3 (de) * 1987-11-23 1990-10-31 Jago Research Ag Verfahren zur Herstellung von therapeutischen Systemen mit gesteuerter Freigabe des Wirkstoffes
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤

Also Published As

Publication number Publication date
EP0583244B1 (de) 1997-01-08
ATE147262T1 (de) 1997-01-15
HK1006808A1 (en) 1999-03-19
DE69124115T2 (de) 1997-07-10
EP0583244A1 (de) 1994-02-23
ES2098495T3 (es) 1997-05-01
JPH06507379A (ja) 1994-08-25
US5085866A (en) 1992-02-04
EP0583244A4 (en) 1994-06-01
WO1992019283A1 (en) 1992-11-12

Similar Documents

Publication Publication Date Title
DE69124115D1 (de) Methode zur herstellung von systemen mit kontrollierter freisetzung nach einer reaktion nullter ordnung
DE3684472D1 (de) Verfahren zur herstellung einer atmosphaerbestaendigen optischen beschichtung, sowie dadurch gefertigte bauteile.
PT90153A (pt) Processo para a preparacao de composicoes farmaceuticas de libertacao controlada
HUT74086A (en) Application form for controlled release of active components and process for preparing thereof
ATE18568T1 (de) Herstellung einer hydrophilischen beschichtung.
ATE73649T1 (de) Mit wirksubstanz beladene biologisch abbaubare substrate, die zur gesteuerten freisetzung der wirksubstanz mit hilfe einer membran geeignet sind.
ATE88887T1 (de) Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung.
ATE64850T1 (de) Allgemeines system zur kontrollierten freisetzung eines wirkstoffes nach einer reaktion nullter ordnung.
EP0614922A3 (de) Verfahren zur Herstellung einer wässrigen Polymerisatdispersion.
DE68923727D1 (de) Verfahren zur Herstellung eines aktiven Matrixsubstrats.
DE59306827D1 (de) Verfahren zur Herstellung einer wässrigen Polymerisatdisperion
DE3689896D1 (de) Verfahren zur Herstellung einer wässrigen Polyurethanharnstoffdispersion.
DE3868700D1 (de) Verfahren zur herstellung eines optisch aktiven alkohols.
DE68921044D1 (de) Verfahren zur Herstellung einer porösen Polytetrafluorethylenfolie.
ATE130436T1 (de) Verfahren zur herstellung einer mit einer immunologisch aktiven substanz beschichteten festphasenmatrix.
ES2018185B3 (es) Soporte de prueba y metodo para la clasificacion de parametros de coagulacion
ATE31049T1 (de) Thermofarbband sowie verfahren zu dessen herstellung.
ES2118735T3 (es) Membrana compuesta semipermeable y procedimiento para su fabricacion.
DE68912862D1 (de) Verfahren zur Herstellung einer kondensierten Harzdispersion.
ATE61575T1 (de) Verfahren zur herstellung von nfluorsulfonamiden.
DE69009237D1 (de) Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure.
ATE41060T1 (de) Verfahren zur herstellung eines immunreaktiven poroesen traegermaterials.
BR9100570A (pt) Processo para a desidratacao de gases e membranas composito para o mesmo
DE59004588D1 (de) Verfahren zur Herstellung von Purpurmembran enthaltend Bacteriorhodopsin.
DE68921131D1 (de) Verfahren zur Herstellung von Bis(aminopropoxy)alkanen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee